Literature DB >> 25266409

Capsule commentary on Tomko et al., A comparison of web- versus print-based decision AIDS for prostate cancer screening: participants' evaluation and utilization.

Elizabeth Kessler1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25266409      PMCID： PMC4284257          DOI： 10.1007/s11606-014-3039-y

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  5 in total

Review 1.  Social ecological predictors of prostate-specific antigen blood test and digital rectal examination in black American men.

Authors:  V Diane Woods; Susanne B Montgomery; R Patti Herring; Robert W Gardner; Daniel Stokols
Journal:  J Natl Med Assoc       Date:  2006-04       Impact factor: 1.798

2.  Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2012-07-17       Impact factor: 25.391

3.  A comparison of web-based versus print-based decision AIDS for prostate cancer screening: participants' evaluation and utilization.

Authors:  Catherine Tomko; Kimberly M Davis; George Luta; Alexander H Krist; Steven H Woolf; Kathryn L Taylor
Journal:  J Gen Intern Med       Date:  2014-09-03       Impact factor: 5.128

4.  Effect of uniform consensus recommendations for PCa screening in older population: differential effects and perceptions of healthcare providers and patients.

Authors:  Badrinath R Konety; Hrishikesh Raut; Brian J Smith; Victoria J Sharp; Richard D Williams
Journal:  Urology       Date:  2009-01-01       Impact factor: 2.649

Review 5.  Process evaluation in randomised controlled trials of complex interventions.

Authors:  Ann Oakley; Vicki Strange; Chris Bonell; Elizabeth Allen; Judith Stephenson
Journal:  BMJ       Date:  2006-02-18
  5 in total
  1 in total

Review 1.  What's new in screening in 2015?

Authors:  Sigrid V Carlsson; Monique J Roobol
Journal:  Curr Opin Urol       Date:  2016-09       Impact factor: 2.309
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.